VIVAGEL
LIVE

Serial Number

79029045

Owner

Starpharma Pty Limited

Filing Date

Mar 27, 2006

Add to watchlist:

No watchlists yet
View on USPTO

VIVAGEL Trademark

Serial Number: 79029045 • Registration: 3784858

VIVAGEL is a trademark filed by Starpharma Pty Limited on March 27, 2006. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Starpharma Pty Limited

Baker Building,

Entity Type: 82

Starpharma Pty Ltd (4 trademarks)

PO 2022

Entity Type: 03

Trademark Details

Filing Date

March 27, 2006

Registration Date

May 4, 2010

Published for Opposition

February 16, 2010

Cancellation Date

February 4, 2021

Goods & Services

Pharmaceuticals, pharmaceutical preparations, and drugs for medical purposes for treatment and prevention of [ viral, ] fungal and bacterial disease, namely, bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV)] ; [ chemical and biological preparations, ] substances for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) ] ; [ reagents and ] compounds for medical purposes; polyvalent compounds, synthetic molecules and dendrimers for medical purposes for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) ] ; antimicrobial preparations, namely, microbicidal preparations in the nature of gels [, foams, creams, films, solutions, suppositories, suspensions and lotions ] for vaginal [, rectal and transdermal ] use for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); contraceptives, namely, oral contraceptives, sponges, gels, foams, creams, films, solutions, suppositories, suspensions and lotions for use in preventing HIV and other sexually transmitted infections ] ; prophylactic preparations for prevention of [ pregnancy and ] disease; gels [, foams, creams, films, solutions, suppositories, suspensions and lotions, ] for the treatment of [ viral, fungal and ] bacterial diseases, namely, bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of human immunodeficiency virus ] ; vaginal gels [ and lubricants ] for the prevention of [ pregnancy and sexually transmitted infections and ] diseases of the human reproductive system

[ Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices ]

Filing History

INTERNATIONAL REGISTRATION RENEWED
Apr 9, 2026 RNWL
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 20, 2023 FINP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Dec 28, 2022 INNA
GENERIC MADRID TRANSACTION SENT TO IB
Dec 23, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 23, 2022 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 4, 2021 INTR
CANCELLED SECTION 71
Feb 4, 2021 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 7, 2019 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Apr 26, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 6, 2018 FINO
NOTIFICATION PROCESSED BY IB
Mar 16, 2018 GPNX
NEW REPRESENTATIVE AT IB RECEIVED
Jul 27, 2017 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Jul 7, 2017 INNP
REFUSAL PROCESSED BY IB
Jun 9, 2017 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
May 18, 2017 NREP
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 5, 2017 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 28, 2017 CRCV
GENERIC MADRID TRANSACTION SENT TO IB
Apr 8, 2017 XXSS
GENERIC MADRID TRANSACTION CREATED
Apr 8, 2017 XXCR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 10, 2017 NREP
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 25, 2017 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 16, 2016 NREP
INTERNATIONAL REGISTRATION RENEWED
Oct 20, 2016 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
May 25, 2016 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
May 25, 2016 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 20, 2016 APRE
TEAS SECTION 71 RECEIVED
May 2, 2016 ES71
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 2, 2016 TCCA
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 5, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 12, 2010 FICS
FINAL DISPOSITION PROCESSED
Aug 12, 2010 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 4, 2010 FICR
REGISTERED-PRINCIPAL REGISTER
May 4, 2010 R.PR
PUBLISHED FOR OPPOSITION
Feb 16, 2010 PUBO
NOTICE OF PUBLICATION
Jan 27, 2010 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 12, 2010 PREV
EXAMINERS AMENDMENT MAILED
Dec 29, 2009 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 29, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 29, 2009 XAEC
EXAMINERS AMENDMENT -WRITTEN
Dec 29, 2009 CNEA
ASSIGNED TO EXAMINER
Sep 16, 2009 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2009 TROA
NON-FINAL ACTION MAILED
Jul 8, 2009 CNRT
NON-FINAL ACTION WRITTEN
Jul 8, 2009 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 19, 2009 RCCK
LETTER OF SUSPENSION MAILED
Dec 2, 2008 CNSL
SUSPENSION LETTER WRITTEN
Dec 1, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2008 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 11, 2008 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 25, 2008 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 25, 2008 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 22, 2008 RCCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 10, 2008 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2008 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 27, 2008 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Mar 13, 2008 NREP
LETTER OF SUSPENSION MAILED
Jan 9, 2008 CNSL
SUSPENSION LETTER WRITTEN
Jan 9, 2008 CNSL
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 14, 2007 RCCK
LETTER OF SUSPENSION MAILED
Jun 12, 2007 CNSL
SUSPENSION LETTER WRITTEN
Jun 11, 2007 CNSL
AMENDMENT FROM APPLICANT ENTERED
May 24, 2007 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2007 CRFA
ASSIGNED TO LIE
May 24, 2007 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2007 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 7, 2007 TCCA
REFUSAL PROCESSED BY IB
Nov 24, 2006 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 7, 2006 RFCS
REFUSAL PROCESSED BY MPU
Nov 7, 2006 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 4, 2006 RFCR
NON-FINAL ACTION WRITTEN
Nov 3, 2006 CNRT
ASSIGNED TO EXAMINER
Oct 27, 2006 DOCK
NEW APPLICATION ENTERED
Oct 27, 2006 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 26, 2006 REPR